Praktische Empfehlungen zur allergologischen Risikoabschätzung der COVID-19-Impfung

Translated title of the contribution: Practical recommendations for the allergological risk assessment of the COVID-19 vaccination - A harmonized statement of allergy centers in Germany

M. Worm, A. Bauer, B. Wedi, R. Treudler, W. Pfuetzner, K. Brockow, T. Buhl, T. Zuberbier, J. Fluhr, G. Wurpts, L. Klimek, T. Jacob, H. F. Merk, N. Mülleneisen, S. Roeseler, H. Dickel, U. Raap, J. Kleine-Tebbe

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Severe allergic reactions to vaccines are very rare. Single severe reactions have occurred worldwide after vaccination with the new mRNA-based COVID-19 vaccines. PEG2000 is discussed as a possible trigger. We provide guidance on risk assessment regarding COVID-19 vaccination in patients with allergic diseases and suggest a standardized, resource-oriented diagnostic and therapeutic procedure. Reports of severe allergic reactions in the context of COVID-19 vaccination can be made via www.anaphylaxie. net using an online questionnaire.

Translated title of the contributionPractical recommendations for the allergological risk assessment of the COVID-19 vaccination - A harmonized statement of allergy centers in Germany
Original languageGerman
Pages (from-to)95-99
Number of pages5
JournalAllergologie
Volume44
Issue number2
DOIs
StatePublished - Feb 2021
Externally publishedYes

Fingerprint

Dive into the research topics of 'Practical recommendations for the allergological risk assessment of the COVID-19 vaccination - A harmonized statement of allergy centers in Germany'. Together they form a unique fingerprint.

Cite this